Human pancreatic cancer fusion 2 (HPC2) 1-B3: A novel monoclonal antibody to screen for pancreatic ductal dysplasia (pages 37–46)
Terry K. Morgan, Karin Hardiman, Christopher L. Corless, Sandra L. White, Robert Bonnah, Henry Van de Vrugt, Brett C. Sheppard, Markus Grompe, Ediz F. Cosar and Philip R. Streeter
Article first published online: 18 JUL 2012 | DOI: 10.1002/cncy.21223
The monoclonal antibody human pancreatic cancer fusion 2 (HPC2) 1-B3 immunostains pancreatic intraductal papillary mucinous neoplasms and ductal adenocarcinoma. This marker also appears to be secreted by dysplastic pancreatic cells, which may lead to a new rapid screening assay.